Clinical Trial

CardioMEMS HF System Coverage With Evidence Development Study

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the CardioMEMS CED Study is to determine if pulmonary artery (PA) pressure-guided heart failure management using the CardioMEMS™ HF System improves long-term health outcomes in heart failure (HF) patients in the real-world setting.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-13; most recent amendment 2026-03-30.
Status change: Not Yet Recruiting → Recruiting 2025-02-14
Trial Details
NCT Number NCT06779552
Lead Sponsor Abbott Medical Devices
Conditions Heart Failure
Enrollment 1,000 participants
Start Date 2025-02-07
Primary Completion 2032-03 (estimated)
Study Completion 2032-03 (estimated)
Updated on ClinicalTrials.gov 2026-04-03